Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-05-20
Target enrollment:
Participant gender:
Summary
Many people with type 2 diabetes cannot maintain target blood glucose levels when taking a
single oral drug. The purpose of this study is to assess the long term safety and
effectiveness of vildagliptin, an unapproved drug, compared to that of glimepiride in
lowering overall blood glucose levels when added to metformin in people with type 2 diabetes
not at target blood glucose levels on metformin alone.